The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
24 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $8,606,885 in first-year total cost, median $349,576.
Most frequent study sections
- Special Emphasis Panel[ZRG1 BST-U (55)]23
- Special Emphasis Panel[ZRG1-BST-U(55)R]1
Most frequent institutions
- SCRIPPS FLORIDA4
- SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE3
- JOHNS HOPKINS UNIVERSITY2
- UNIVERSITY OF MICHIGAN AT ANN ARBOR2
- UNIVERSITY OF PITTSBURGH AT PITTSBURGH2
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2015 | High Throughput Screening to Discover Ulk1 Kinase Inhibitors1R01GM113972-01 | CLEVELAND, JOHN L.DUCKETT, DEREK RONALD | SCRIPPS FLORIDA, FL | $621,865 | ZRG1 |
| 2015 | Identification and development of inhibitors of the Hippo-Yap pathway1R01CA184277-01A1 | KISSIL, JOSEPHSCAMPAVIA, LOUIS DANIEL | SCRIPPS FLORIDA, FL | $439,200 | ZRG1 |
| 2015 | HTS for Identification of Novel Inhibitors of Pyk2 Activity1R01CA193382-01 | LOFTUS, JOSEPH C | MAYO CLINIC ARIZONA, AZ | $436,028 | ZRG1 |
| 2015 | HCS to Identify Inhibitors and Disruptors of AR-TIF2 Interactions1R01CA183882-01A1 | JOHNSTON, PAUL A. | UNIVERSITY OF PITTSBURGH AT PITTSBURGH, PA | $389,435 | ZRG1 |
| 2015 | Targeting BRCA Deficient Cells for Killing1R01CA190237-01 | POMERANTZ, RICHARD T | TEMPLE UNIV OF THE COMMONWEALTH, PA | $356,850 | ZRG1 |
| 2015 | Targeting MLL3 histone methyltransferase1R01CA187004-01A1 | DOU, YALI | UNIVERSITY OF MICHIGAN AT ANN ARBOR, MI | $354,848 | ZRG1 |
| 2015 | Discovery of Selective MAP2K4 Inhibitors to Target Metastasis1R01CA188015-01A1 | SCHEIDT, KARL A | NORTHWESTERN UNIVERSITY, IL | $346,802 | ZRG1 |
| 2015 | Identification of chemical probes that specifically disrupt the GIV-Gi interface1R01GM112631-01 | GARCIA-MARCOS, MIKEL | BOSTON UNIVERSITY MEDICAL CAMPUS, MA | $311,030 | ZRG1 |
| 2015 | High Throughput Screening to Discover Chemical Probes and Pharmacological Agents for Modulating Parkin Activity1R01GM113141-01A1 | LIU, XUEDONG | UNIVERSITY OF COLORADO, CO | $298,704 | ZRG1 |
| 2015 | High-throughput Discovery of Chemical Probes for HIV-1 Nef Function1R01GM111086-01A1 | SMITHGALL, THOMAS E. | UNIVERSITY OF PITTSBURGH AT PITTSBURGH, PA | $296,450 | ZRG1 |
| 2015 | HTS for selective inhibitors of Meprin alpha and beta1R01AR066676-01A1 | MINOND, DMITRIYSCAMPAVIA, LOUIS DANIEL | TORREY PINES INST FOR MOLECULAR STUDIES, FL | $174,915 | ZRG1 |
| 2015 | Identifying CXCR4 Receptor Agonists to Improve Diabetic Healing1R56DK105010-01 | LIECHTY, KENNETH W | SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE, CA | $97,500 | ZRG1 |
| 2014 | Identification of Rev-Erb alpha/beta nuclear receptor modulators1R01DK101520-01 | RASTINEJAD, FRAYDOON | SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE, CA | $529,751 | ZRG1 |
| 2014 | High-throughput screening for NAD+-replenishing neuroprotective compounds1R01NS085223-01A1 | LASMEZAS, CORINNE IDASCAMPAVIA, LOUIS DANIEL | SCRIPPS FLORIDA, FL | $484,603 | ZRG1 |
| 2014 | HTS for Direct Targeting of the Transcription Factor MITF1R01CA178315-01A1 | GUO, MINSCAMPAVIA, LOUIS DANIEL | SCRIPPS FLORIDA, FL | $482,741 | ZRG1 |
| 2014 | NOVEL DNA DOUBLE STRAND BREAK REPAIR TARGETING THERAPEUTICS FOR CANCER TREATMENT1R01CA177759-01A1 | SKLAR, LARRY A.SLECKMAN, BARRY P | WASHINGTON UNIVERSITY, MO | $462,633 | ZRG1 |
| 2014 | Identification of Specific Modulators of NR3-containing Glutamate Receptors1R01HD074961-01A1 | ZHANG, DONGXIAN | SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE, CA | $404,625 | ZRG1 |
| 2014 | Chemical probes targeting nuclear effector complex of the Hippo signaling pathway1R01DK098424-01A1 | PAN, DUOJIA | JOHNS HOPKINS UNIVERSITY, MD | $352,350 | ZRG1 |
| 2014 | Small molecule stabilizers of RGS protein expression1R01GM110195-01 | NEUBIG, RICHARD R | MICHIGAN STATE UNIVERSITY, MI | $340,468 | ZRG1 |
| 2014 | Inhibition of CDC25B phosphatase by targeting protein-protein interactions1R01CA181185-01 | CIERPICKI, TOMASZ | UNIVERSITY OF MICHIGAN AT ANN ARBOR, MI | $317,857 | ZRG1 |
| 2014 | Probes for a tRNA modification enzyme1R01GM108972-01A1 | HOU, YA-MING | THOMAS JEFFERSON UNIVERSITY, PA | $294,817 | ZRG1 |
| 2014 | High Throughput Screening for Small-molecules Facilitating Prion Study1R01GM110045-01 | LI, LIMING | NORTHWESTERN UNIVERSITY AT CHICAGO, IL | $288,772 | ZRG1 |
| 2014 | High-throughput screen targeting Wolbachia to combat filarial diseases1R01GM104486-01A1 | SULLIVAN, WILLIAM T. | UNIVERSITY OF CALIFORNIA SANTA CRUZ, CA | $283,666 | ZRG1 |
| 2014 | High Throughput Screening for Identification of Human Cytomegalovirus Inhibitors1R01DC013550-01A1 | BOGER, RAVIT | JOHNS HOPKINS UNIVERSITY, MD | $240,975 | ZRG1 |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.